Markets experienced broad-based weakness this week, with most major ETFs and sector benchmarks declining as investor ...
Growth-oriented indices such as the Invesco NASDAQ 100 ETF and broader market proxies like the State Street SPDR Portfolio ...
The results indicate that this methodology applied at the end of 2023 resulted in a strong top ten list in 2024. In a year that the Standard & Poor’s SPIVA (S&P vs. Active) blog reported that more ...
Volatility continues to define the early weeks of 2026, with markets swinging back and forth in short one-to-two day cycles. While headline indexes have struggled to establish sustained momentum, ...
ValuEngine is a subscription-based business intelligence, market and equity analysis firm that provides exclusive, customized research and analysis solutions directly to companies, investors, ...
ValuEngine produces 12-page PDF reports every day for around 4,100 US stocks using two distinct models—a valuation model, and a forecast model that uses the valuation model but also delivers short- ...
ValuEngine lowered its rating on Surgery Partners’ shares from a “hold” to a “sell,” according to The Ledger Gazette. 1. Surgery Partners’ shares opened Nov. 24 trading at $8.60 per share. 2. The ...
ValuEngine is a subscription-based business intelligence, market and equity analysis firm that provides exclusive, customized research and analysis solutions directly to companies, investors, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results